Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 5
Results: 14
Editorial Board: Arch Pharm (5/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202270011
- Publication type:
- Article
Cover Picture: Arch Pharm (5/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202270010
- Publication type:
- Article
C5‐Iminosugar modification of casein kinase 1δ lead 3‐(4‐fluorophenyl)‐5‐isopropyl‐4‐(pyridin‐4‐yl)isoxazole promotes enhanced inhibitor affinity and selectivity.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100497
- By:
- Publication type:
- Article
Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100487
- By:
- Publication type:
- Article
Current perspectives on naturally occurring saponins as anticancer agents.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100469
- Publication type:
- Article
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100467
- By:
- Publication type:
- Article
Upregulation of BAX and caspase‐3, as well as downregulation of Bcl‐2 during treatment with indeno[1,2‐b]quinoxalin derivatives, mediated apoptosis in human cancer cells.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100454
- By:
- Publication type:
- Article
Synthesis of cinnamils and quinoxalines and their biological evaluation as anticancer agents.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100448
- By:
- Publication type:
- Article
Microwave‐assisted N‐alkylation of amines with alcohols catalyzed by MnCl<sub>2</sub>: Anticancer, docking, and DFT studies.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100443
- By:
- Publication type:
- Article
Molecular docking studies of YKT tripeptide and drug delivery system with poly(ε‐caprolactone) nanoparticles.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100437
- By:
- Publication type:
- Article
A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS‐CoV‐2.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100382
- By:
- Publication type:
- Article
Novel substituted 5‐methyl‐4‐acylaminoisoxazoles as antimitotic agents: Evaluation of selectivity to LNCaP cancer cells.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100425
- By:
- Publication type:
- Article
Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100360
- By:
- Publication type:
- Article
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 5, p. 1, doi. 10.1002/ardp.202100313
- By:
- Publication type:
- Article